CVS HEALTH (CVS.SG)
CVS HEALTH (CVS.SG) operates in Diversified Metals & Mining.
CVS HEALTH (CVS.SG) (CVS) - Net Assets
Latest net assets as of September 2024: €75.11 Billion EUR
Based on the latest financial reports, CVS HEALTH (CVS.SG) (CVS) has net assets worth €75.11 Billion EUR as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€252.43 Billion) and total liabilities (€177.32 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €75.11 Billion |
| % of Total Assets | 29.75% |
| Annual Growth Rate | 11.04% |
| 5-Year Change | 19.43% |
| 10-Year Change | N/A |
| Growth Volatility | 18.16 |
CVS HEALTH (CVS.SG) - Net Assets Trend (2016–2023)
This chart illustrates how CVS HEALTH (CVS.SG)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CVS HEALTH (CVS.SG) (2016–2023)
The table below shows the annual net assets of CVS HEALTH (CVS.SG) from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €76.64 Billion | +6.78% |
| 2022-12-31 | €71.77 Billion | -4.79% |
| 2021-12-31 | €75.38 Billion | +8.15% |
| 2020-12-31 | €69.70 Billion | +8.62% |
| 2019-12-31 | €64.17 Billion | +9.61% |
| 2018-12-31 | €58.54 Billion | +55.31% |
| 2017-12-31 | €37.70 Billion | +2.34% |
| 2016-12-31 | €36.83 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to CVS HEALTH (CVS.SG)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 58.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €61.60 Billion | 80.57% |
| Other Components | €14.86 Billion | 19.43% |
| Total Equity | €76.46 Billion | 100.00% |
CVS HEALTH (CVS.SG) Competitors by Market Cap
The table below lists competitors of CVS HEALTH (CVS.SG) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Global Copper Corp.
V:CUCU
|
$631.13K |
|
Brimag -L
TA:BRMG
|
$631.90K |
|
SAAB AB B O.N.
F:SDV1
|
$631.98K |
|
Amiad Water Systems Ltd
TA:AMD
|
$632.09K |
|
Boeing Co
NYSE:BA-PA
|
$630.83K |
|
HEINEKEN HOLDING
MU:4H5
|
$630.83K |
|
Cleghorn Minerals Ltd
V:CZZ
|
$630.60K |
|
Chanson International Holding Class A Ordinary Shares
NASDAQ:CHSN
|
$630.41K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CVS HEALTH (CVS.SG)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 71,469,000,000 to 76,461,000,000, a change of 4,992,000,000 (7.0%).
- Net income of 8,344,000,000 contributed positively to equity growth.
- Dividend payments of 3,132,000,000 reduced retained earnings.
- Share repurchases of 2,012,000,000 reduced equity.
- Other factors increased equity by 1,792,000,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €8.34 Billion | +10.91% |
| Dividends Paid | €3.13 Billion | -4.1% |
| Share Repurchases | €2.01 Billion | -2.63% |
| Other Changes | €1.79 Billion | +2.34% |
| Total Change | €- | 6.98% |
Book Value vs Market Value Analysis
This analysis compares CVS HEALTH (CVS.SG)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.11x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.78x to 1.11x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €37.17 | €66.05 | x |
| 2018-12-31 | €44.96 | €66.05 | x |
| 2019-12-31 | €49.05 | €66.05 | x |
| 2020-12-31 | €52.97 | €66.05 | x |
| 2021-12-31 | €56.79 | €66.05 | x |
| 2022-12-31 | €54.98 | €66.05 | x |
| 2023-12-31 | €59.36 | €66.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CVS HEALTH (CVS.SG) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.91%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.33%
- • Asset Turnover: 1.43x
- • Equity Multiplier: 3.27x
- Recent ROE (10.91%) is above the historical average (9.90%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 14.44% | 3.00% | 1.88x | 2.56x | €1.63 Billion |
| 2017 | 17.57% | 3.58% | 1.94x | 2.52x | €2.85 Billion |
| 2018 | -1.02% | -0.31% | 0.99x | 3.37x | €-6.42 Billion |
| 2019 | 10.39% | 2.58% | 1.15x | 3.48x | €247.60 Million |
| 2020 | 10.35% | 2.67% | 1.16x | 3.32x | €240.10 Million |
| 2021 | 10.54% | 2.71% | 1.25x | 3.10x | €402.50 Million |
| 2022 | 6.03% | 1.34% | 1.41x | 3.19x | €-2.84 Billion |
| 2023 | 10.91% | 2.33% | 1.43x | 3.27x | €697.90 Million |
Industry Comparison
This section compares CVS HEALTH (CVS.SG)'s net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CVS HEALTH (CVS.SG) (CVS) | €75.11 Billion | 14.44% | 2.36x | $631.00K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |